Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients.  Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.

Biotechnology

Neurotech Pharmaceuticals, Inc.

Neurotech Pharmaceuticals, Inc.'s headquarters in Cumberland, RI, United States

Richard Small

Laurie Ferguson

Tim Scannell

Paul Brannelly

Jacob Patterson Esq.

Arne Nystuen

Patricia Davis (Patty)

Derek Barnett

Description

People (17)

Matthew Fera

Scott Bertolami

Joel C.

Ralph Cook

Mike Bradley

Derek Barnett

Aiden Clasby

Roy Konyeaso

Emmanuel Tagoe

Kaitlyn Greenwood

Laura Thibodeau

Leslie Simonelli

Pam Legare

Julie Sousa (Julieta)

Stephanie Storch

Vanessa Cavallaro

Tim Scannell

Jobs